Thrombin-Antithrombin Complex (TAT)
Target/reference protein material for calibration or control concepts, antibody characterization and analytical evaluation in TAT-related assay development. Thrombin–antithrombin complex target reflecting in-vivo thrombin generation/coagulation activation.
Product Type
Antibodies & Antigens
Sub-Category
Functional & Reference Proteins
Platform
CLIA
Application
THR
Overview
Target/reference protein material for calibration or control concepts, antibody characterization and analytical evaluation in TAT-related assay development. Thrombin–antithrombin complex target reflecting in-vivo thrombin generation/coagulation activation.
Target/reference protein material for calibration or control concepts, antibody characterization and analytical evaluation in TAT-related assay development. Thrombin–antithrombin complex target reflecting in-vivo thrombin generation/coagulation activation. TAT forms when generated thrombin is neutralized by antithrombin and is studied as a marker of coagulation activation. It can provide mechanistic information complementary to conventional hemostasis tests.
Professional Context
TAT forms when generated thrombin is neutralized by antithrombin and is studied as a marker of coagulation activation. It can provide mechanistic information complementary to conventional hemostasis tests.
Technical Specifications
Antibody Information
| Parameter | Specification |
|---|---|
| Target | TAT |
| Technology Platform | Chemiluminescence |
| Application Tags | THR |
| Storage | -25~ -10℃ |
| Shelf Life | 1年 |
| Sample Pack | 0.1mg |
Target
TAT
Technology Platform
Chemiluminescence
Application Tags
THR
Storage
-25~ -10℃
Shelf Life
1年
Sample Pack
0.1mg
Technical Resources
Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.
Need to confirm the right product or material for your project?
Our technical team can assist with product selection, provide samples, and support your IVD development project.





